May 21, 2013 in Africa, Business, Good News, Philanthropy
A new era of morality in business; pharmaceutical industry giants joining forces with prominent charities
The pharmaceutical industry has been weathering public controversies for decades, not only in dealing with damage control on countless patents that are either proven to be ineffective or dangerous, but also with the crushing cost of their drugs in developing countries. This last point has been painfully obvious with anti-malarial agents and HIV treatment; both are usually priced far beyond the means of those that most desperately need them.
Now things are beginning to look better. The BBC recently reported that Britain’s drug giant, GlaxoSmithKline, is radically changing tack and joining the much-needed philanthropic drive to save the lives of millions in Africa by joining forces with prominent charities like Save the Children. Read the rest of this entry →
February 13, 2012 in Change, Inspiration, Philanthropy
Sir Andrew Witty, chief executive of Britain’s GlaxoSmithKline, said this, “The biggest achievement over the last year, I think, has been to get some of the companies to really massively increase their commitments, so that everybody is kind of at this at an industrial level. I hope that what everybody is going to see today is an industry at its best, actually.”
Just when you thought that money ruled everything, along comes a story that gives you hope. It seems the age-old gripe against the pharmaceutical industry of inflated prices and restricted patents for third world health care has just had a volte-face – and it doesn’t seem like a PR stunt! The Guardian newspaper reports that a new initiative to rid the poorest countries of antiquated diseases that still kill millions is moving briskly ahead, thanks to the philanthropic pursuits of the Bill Gates Foundation and the World Health Organization.
Read the rest of this entry →